Paper26123787
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.
Harada K and 17 others. Dis Esophagus, 2016. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Papers, record 26123787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26123787
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anastomotic Leak | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Chemoradiotherapy | Major topic |
| Esophageal Neoplasms | Major topic |
| Esophagectomy | Major topic |
| Sarcopenia | Major topic |
| Aged | |
| Esophageal Squamous Cell Carcinoma | |
| Female | |
| Humans | |
| Japan | |
| Lymph Nodes | |
| Male | |
| Middle Aged | |
| Muscle, Skeletal | |
| Neoplasm Staging | |
| Postoperative Complications | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate | |
| Tomography, X-Ray Computed |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42760927 | Perioperative phase angle decline is associated with postoperative sarcopenia in esophageal cancer: a longitudinal cohort study with internal validation. | Front Nutr | 2026 | https://conductscience.org/library/papers/42760927 | PubMed |
| 42429839 | Sarcopenia as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42429839 | PubMed |
| 41821148 | Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy. | Cancer Med | 2026 | https://conductscience.org/library/papers/41821148 | PubMed |
| 41799582 | Exercise and Nutrition Prehabilitation Program During Preoperative Chemotherapy Followed by Esophagectomy in Older Patients With Esophageal Cancer: A Randomized Clinical Trial. | Ann Gastroenterol Surg | 2026 | https://conductscience.org/library/papers/41799582 | PubMed |
| 41502437 | Effects of β-hydroxy-β-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma. | Ann Transl Med | 2025 | https://conductscience.org/library/papers/41502437 | PubMed |
| 41016991 | Correlation of growth differentiation factor 15 level in esophageal cancer with cachectic indicators and postoperative infectious complication. | Esophagus | 2026 | https://conductscience.org/library/papers/41016991 | PubMed |
| 39883331 | Low skeletal muscle mass contributes to the prognosis of patients with superficial esophageal cancer treated with definitive chemoradiotherapy. | Esophagus | 2025 | https://conductscience.org/library/papers/39883331 | PubMed |
| 39766116 | Effect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy-A Retrospective Cohort Study. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39766116 | PubMed |
| 39104037 | A sarcopenia screening test predicts mortality among hospitalized cancer patients. | Physiol Rep | 2024 | https://conductscience.org/library/papers/39104037 | PubMed |
| 37999111 | Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37999111 | PubMed |
| 37989955 | Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/37989955 | PubMed |
| 37873749 | May Nutritional Status Positively Affect Disease Progression and Prognosis in Patients with Esophageal and Pharyngeal Cancers? A Scoping Review of the Current Clinical Studies. | Med Sci (Basel) | 2023 | https://conductscience.org/library/papers/37873749 | PubMed |
| 37814177 | The Influence of Strength and Speed on Survival in Esophageal Cancer. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/37814177 | PubMed |
| 37592262 | The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis. | BMC Surg | 2023 | https://conductscience.org/library/papers/37592262 | PubMed |
| 37316578 | Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study. | Sci Rep | 2023 | https://conductscience.org/library/papers/37316578 | PubMed |
| 37240466 | Sarcopenia Is a Prognostic Factor in Patients Undergoing Percutaneous Endoscopic Gastrostomy. | J Clin Med | 2023 | https://conductscience.org/library/papers/37240466 | PubMed |
| 37101772 | Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making? | Eur Urol Open Sci | 2023 | https://conductscience.org/library/papers/37101772 | PubMed |
| 36763134 | Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis. | Surg Today | 2023 | https://conductscience.org/library/papers/36763134 | PubMed |
| 36631713 | Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma. | Esophagus | 2023 | https://conductscience.org/library/papers/36631713 | PubMed |
| 36415154 | The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/36415154 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26123787
GET https://conductscience.org/api/papers/v1/26123787/cited_by?page=2